Matt Meyerson headshot

Matt Meyerson

Charles A. Dana Chair in Human Cancer Genetics, Dana-Farber Cancer Institute
Professor of Genetics and Medicine, Harvard Medical School
Director, Center for Cancer Genomics, Dana-Farber Cancer Institute
Dana Farber Cancer Institute
617-632-4377
Meyerson Lab
Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.
Authors: Authors: George RE, Attiyeh EF, Li S, Moreau LA, Neuberg D, Li C, Fox EA, Meyerson M, Diller L, Fortina P, Look AT, Maris JM.
PLoS One
View full abstract on Pubmed
Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing.
Authors: Authors: Sequist LV, Joshi VA, Jänne PA, Muzikansky A, Fidias P, Meyerson M, Haber DA, Kucherlapati R, Johnson BE, Lynch TJ.
Oncologist
View full abstract on Pubmed
Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling.
Authors: Authors: Kobayashi S, Shimamura T, Monti S, Steidl U, Hetherington CJ, Lowell AM, Golub T, Meyerson M, Tenen DG, Shapiro GI, Halmos B.
Cancer Res
View full abstract on Pubmed
Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.
Authors: Authors: Lee JC, Vivanco I, Beroukhim R, Huang JH, Feng WL, DeBiasi RM, Yoshimoto K, King JC, Nghiemphu P, Yuza Y, Xu Q, Greulich H, Thomas RK, Paez JG, Peck TC, Linhart DJ, Glatt KA, Getz G, Onofrio R, Ziaugra L, Levine RL, Gabriel S, Kawaguchi T, O'Neill K, Khan H, Liau LM, Nelson SF, Rao PN, Mischel P, Pieper RO, Cloughesy T, Leahy DJ, Sellers WR, Sawyers CL, Meyerson M, Mellinghoff IK.
PLoS Med
View full abstract on Pubmed
Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts.
Authors: Authors: Hayes DN, Monti S, Parmigiani G, Gilks CB, Naoki K, Bhattacharjee A, Socinski MA, Perou C, Meyerson M.
J Clin Oncol
View full abstract on Pubmed
Phosphorylation of the menin tumor suppressor protein on serine 543 and serine 583.
Authors: Authors: MacConaill LE, Hughes CM, Rozenblatt-Rosen O, Nannepaga S, Meyerson M.
Mol Cancer Res
View full abstract on Pubmed
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.
Authors: Authors: Perner S, Demichelis F, Beroukhim R, Schmidt FH, Mosquera JM, Setlur S, Tchinda J, Tomlins SA, Hofer MD, Pienta KG, Kuefer R, Vessella R, Sun XW, Meyerson M, Lee C, Sellers WR, Chinnaiyan AM, Rubin MA.
Cancer Res
View full abstract on Pubmed
C/EBP alpha mutations in lung cancer.
Authors: Authors: Costa DB, Dayaram T, D'Alo F, Wouters BJ, Tenen DG, Meyerson M, Tsao MS, Halmos B.
Lung Cancer
View full abstract on Pubmed
Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents.
Authors: Authors: Lynch TJ, Adjei AA, Bunn PA, Eisen TG, Engelman J, Goss GD, Haber DA, Heymach JV, Jänne PA, Johnson BE, Johnson DH, Lilenbaum RC, Meyerson M, Sandler AB, Sequist LV, Settleman J, Wong KK, Hart CS.
Clin Cancer Res
View full abstract on Pubmed
Genomic approaches to lung cancer.
Authors: Authors: Thomas RK, Weir B, Meyerson M.
Clin Cancer Res
View full abstract on Pubmed